Multidrug resistance-associated protein 1 (MRP1) mediated vincristine resistance: effects of N-acetylcysteine and Buthionine sulfoximine
about
Redox Control of Multidrug Resistance and Its Possible Modulation by AntioxidantsMultidrug Resistance Proteins (MRPs) and Cancer TherapyAllyl isothiocyanate increases MRP1 function and expression in a human bronchial epithelial cell lineDetection approaches for multidrug resistance genes of leukemia.Non-coding polymorphisms in nucleotide binding domain 1 in ABCC1 gene associate with transcript level and survival of patients with breast cancer.HZ08 reverse P-glycoprotein mediated multidrug resistance in vitro and in vivo.Impact of terminal dimethylation on the resistance profile of α-N-heterocyclic thiosemicarbazonesMechanisms and strategies to overcome multiple drug resistance in cancer.Different Expression of Extracellular Signal-Regulated Kinases (ERK) 1/2 and Phospho-Erk Proteins in MBA-MB-231 and MCF-7 Cells after Chemotherapy with Doxorubicin or DocetaxelDual roles of Nrf2 in cancer.Hepatocyte SLAMF3 reduced specifically the multidrugs resistance protein MRP-1 and increases HCC cells sensitization to anti-cancer drugs.Delineating the Role of βIV-Tubulins in Pancreatic Cancer: βIVb-Tubulin Inhibition Sensitizes Pancreatic Cancer Cells to Vinca Alkaloids.Mechanism of cell adaptation: when and how do cancer cells develop chemoresistance?Parthenolide, a sesquiterpene lactone, expresses multiple anti-cancer and anti-inflammatory activities.Cancer cell resistance mechanisms: a mini review.Importance of ABCC1 for cancer therapy and prognosis.MRP1 and its role in anticancer drug resistance.Effects of surfactants on the properties of PLGA nanoparticles.Effects of N-acetylcystein on bleomycin-induced apoptosis in malignant testicular germ cell tumors.Modulation of doxorubicin resistance by the glucose-6-phosphate dehydrogenase activity.Combined use of anticancer drugs and an inhibitor of multiple drug resistance-associated protein-1 increases sensitivity and decreases survival of glioblastoma multiforme cells in vitro.Effect of COPD treatments on MRP1-mediated transport in bronchial epithelial cells.Involvement of reactive oxygen species in multidrug resistance of a vincristine-selected lymphoblastoma.Changes in intracellular redox status influence multidrug resistance in gastric adenocarcinoma cells.Differential involvement of glutathione S-transferase mu 1 and multidrug resistance protein 1 in melanoma acquired resistance to vinca alkaloids.Exogenous glutathione contributes to cisplatin resistance in lung cancer A549 cells.
P2860
Q26765805-D10DA30C-1E9E-4FEF-8E1E-8FF4206FF219Q26992204-02FBA603-87C3-4624-89DA-F3977B09731CQ28396851-29392E89-2F21-46E2-A518-1C1969C6D7E8Q33596508-9E049160-73D6-4AC1-9DE1-8EFC4E847EE7Q33982601-6BED7466-508C-4BDA-9D09-4F3EE9E3078CQ35091852-C5919624-CF9E-4CBE-96D2-E18FEFCFE484Q35928856-E010EAFF-D20D-4DB3-B865-568E1344EFF0Q36404538-98DAD8B7-7356-49F1-A42A-C73D5873D185Q36652542-CF9CF79F-5E0C-4BFB-9AEB-975FA9AC85B5Q37119963-38C8C69E-3EC8-403C-BB50-2B14565DEC9CQ37362692-FAB91C58-B35D-485E-A710-2CF1EF062AF6Q37447324-1AB68A57-2383-40FA-A05C-F0F5392F6E32Q37856115-6B32085C-F846-4DE2-95F3-09F984A17350Q37878390-6AD07E7C-A88C-425E-A6E3-678A8A02AB94Q38197531-08521F7E-A3D5-4E3E-A60E-606F82019321Q38199535-48EDA30A-EDAF-4812-902B-C3E3BF3407F5Q38626237-2AEFF6AA-FD6F-46A3-AE4C-72BBE9A1C353Q39352101-4114C501-EBB5-4AD8-8620-93AE40C5ECA2Q39353035-52FC84FF-CA9E-4E2E-9A98-8012F11B6B8EQ39523446-FED353E3-3340-42F2-9030-982DFF2D3ECBQ39547831-40982D81-D7B9-44A1-92BD-CAF04F08DC7DQ39920199-CABDC541-4C92-4E01-8DEC-7D37F9F7F824Q40129773-B0804199-4729-41BF-9EB6-00FFBC435AA2Q42571058-DB9FB51D-01FB-4954-9237-CB0B76668090Q46207470-2E6638C5-DB4A-4274-AAF7-3361E1D4B648Q55261457-0FB25375-CA06-4065-B7E1-E9E47549812C
P2860
Multidrug resistance-associated protein 1 (MRP1) mediated vincristine resistance: effects of N-acetylcysteine and Buthionine sulfoximine
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Multidrug resistance-associate ...... ine and Buthionine sulfoximine
@ast
Multidrug resistance-associate ...... ine and Buthionine sulfoximine
@en
Multidrug resistance-associate ...... ine and Buthionine sulfoximine
@nl
type
label
Multidrug resistance-associate ...... ine and Buthionine sulfoximine
@ast
Multidrug resistance-associate ...... ine and Buthionine sulfoximine
@en
Multidrug resistance-associate ...... ine and Buthionine sulfoximine
@nl
prefLabel
Multidrug resistance-associate ...... ine and Buthionine sulfoximine
@ast
Multidrug resistance-associate ...... ine and Buthionine sulfoximine
@en
Multidrug resistance-associate ...... ine and Buthionine sulfoximine
@nl
P2093
P2860
P3181
P356
P1476
Multidrug resistance-associate ...... ine and Buthionine sulfoximine
@en
P2093
Burhan Savas
Hakan Akca
Ilhan Akan
Selma Akan
P2860
P2888
P3181
P356
10.1186/1475-2867-5-22
P407
P50
P577
2005-07-24T00:00:00Z
P5875
P6179
1026637330